BIOHENG
BioHeng is a clinical biopharmaceutical and biotechnology Company focuses on novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. Founded in 2017, Bioheng has established a high standard GMP grade clinical translational center, and is leading in the field of cell engineering, proliferation and clinical applications. Particularly, Bioheng owns several cutting-edge patents plus extensive industry experience, and has built a complete, closed an... d automated production system in compliance with regulatory guidelines. In 2018, Bioheng has successfully raised tens of millions of RMB seeding fund from Simcere Pharmaceutical Group, aiming to accelerate the development of immunotherapy via integrating resources from both parties. Bioheng is dedicated to develop safer, effective and less expensive cell therapy drugs to benefit more patients.
BIOHENG
Industry:
Biopharma Biotechnology Clinical Trials Health Care Innovation Management
Founded:
2017-01-01
Address:
Nanjing, Jiangsu, China
Country:
China
Website Url:
http://www.bioheng.com
Total Employee:
1+
Status:
Active
Contact:
400-828-8076
Email Addresses:
[email protected]
Total Funding:
620 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Mobile Non Scaleable Content Apple Mobile Web App Capable JQuery CDN Apple Mobile Web App Status Bar Style Cart Functionality HiChina DNS
Similar Organizations
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
IFTech
IFTech Inventing Future Technology Inc. is a high tech innovation company.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Yisheng Biopharma
Yisheng Biopharma is a global, fully integrated bio-pharmaceutical company.
Current Employees Featured
Founder
Investors List
Hillhouse Capital Group
Hillhouse Capital Group investment in Series B - Bioheng
Octagon Capital Partners
Octagon Capital Partners investment in Series B - Bioheng
Decheng Capital
Decheng Capital investment in Series B - Bioheng
GL Ventures
GL Ventures investment in Series B - Bioheng
BlueRun Ventures
BlueRun Ventures investment in Series B - Bioheng
Min Cui
Min Cui investment in Series B - Bioheng
Shenzhen Capital Group
Shenzhen Capital Group investment in Series B - Bioheng
Decheng Capital
Decheng Capital investment in Series A - Bioheng
Official Site Inspections
http://www.bioheng.com
- Host name: 123.59.154.172
- IP address: 123.59.154.172
- Location: Beijing China
- Latitude: 39.9288
- Longitude: 116.3889
- Timezone: Asia/Shanghai